跳至主要内容
临床试验/NCT06753825
NCT06753825进行中(未招募)不适用

Comparison of the Efficacy of Transcutaneous Pulsed Radiofrequency Therapy and Calcium Channel Blockers in Childhood Migraine Headache.

Damla Yürük1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2024年10月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
60
试验地点
1
主要终点
Headache diary

研究概览

简要总结

The aim of this observational study was to investigate the long-term effects of patients receiving interventional transcutaneous electrode-pulsed radiofrequency therapy versus calcium channel blockers for the treatment of childhood migraine pain. The main question to be answered was.

Which of the long-term effects of interventional transcutaneous pulsed radiofrequency versus calcium channel blockers for the treatment of childhood migraine pain is more effective? Participants who have started both treatments will answer questions about their headaches in an online survey for 3 months as part of their regular medical care.

详细描述

There are two groups in the trial. One group will receive transcutaneous pulsed radiofrequency treatment for a total of 3 weekly sessions. The other group will receive 1x 5 mg flunarizine active ingredient. Both groups will consist of 30 patients. All patients will be followed from the start of treatment and will be assessed at month 1 and month 3 using the paediatric migraine disability index, headache diaries and visual pain scale.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
7 Years 至 17 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Diagnosed with migraine according to ICHD-3 Migraine criteria
  • Being between the ages of 8-18
  • Having 4 or more migraine attacks per month

排除标准

  • Other primary or secondary headache diagnosis
  • Patient could not be reached during follow-up

研究组 & 干预措施

group pulsed radiofrequency

The group receiving pulsed radiofrequency therapy via transcutaneous electrodes receives 2 sessions of treatment, each lasting 8 minutes, once a week.

干预措施: Radiofrequency (Device)

group medical teratment

The group receiving 5 mg flunarizine treatment per day

干预措施: flunarizine (Drug)

结局指标

主要结局

Headache diary

时间窗: month 1 and month 3

The headache diary : including the date, triggering event, severity (rated on a scale from 1-very mild- to 5-very severe-), type, location of the pain. Additional symptoms such as nausea, vomiting, light sensitivity, sound sensitivity, and dizziness and duration of the pain, and whether daily activities were impacted are recorded.

次要结局

  • Pediatrik migraine disability scale PedMidas(month 1 and month 3)

研究者

发起方
Damla Yürük
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Damla Yürük

medical doctor

Diskapi Teaching and Research Hospital

研究点 (1)

Loading locations...

相似试验

Childhood Migraine Treatment Noninvasive Pulsed... | 临床试验